ACS predicts that cancer survivors will number nearly 19 million by 2024

The number of cancer survivors in the United States, currently estimated to be 14.5 million, will grow to almost 19 million by 2024, according to an updated report by the American Cancer Society (ACS).

Even though cancer incidence rates have been decreasing for 10 years, the number of cancer survivors is growing, according to the second edition of Cancer Treatment & Survivorship Facts & Figures, 2014-2015 and an accompanying journal article published in CA: A Cancer Journal for Clinicians (2014; doi:10.3322/caac.21235). This is the result of increases in cancer diagnoses driven by the aging and growth of the population, as well as the fact that people are living longer with cancer because of earlier cancer detection and more effective treatments.

The three most common cancers among males living with a history of cancer in 2014 are prostate (43%), colorectal (9%), and melanoma (8%). Among women in 2014, the three most common cancers are breast (41%), uterine (8%), and colorectal (8%). While lung cancer is the leading cause of cancer death and the second most commonly diagnosed cancer in both men and women, a low survival rate makes it the number eight cancer site represented among survivors. The distribution of prevalent cancers is expected to be largely unchanged in 2024.

The study also found that the majority of cancer survivors (64%) were diagnosed 5 or more years previously, and 15% were diagnosed 20 or more years ago. Nearly one-half of cancer survivors (46%) are age 70 years or older, while 1 in 20 (5%) is younger than 40 years.

The age distribution of cancer survivors varies substantially by cancer type. For example, the majority of prostate cancer survivors (62%) are 70 and older, whereas less than one-third (32%) of melanoma survivors are in this age group.

By January 1, 2024, it is estimated that the population of cancer survivors will increase to nearly 19 million people (9.3 million males and 9.6 million females).

In addition to prevalence estimates, the reports also include data on cancer treatment patterns, survival, and information on common short- and long-term effects of cancer and its treatment for 11 selected cancers. The report also contains sections on the effects of cancer and its treatment, impairment-driven cancer rehabilitation, palliative care, long term survivorship, the benefits of healthy behaviors, and resources for cancer survivors from the American Cancer Society and other organizations.

“The growing number of cancer survivors in the [United States] makes it increasingly important to understand the unique medical and psychosocial needs of survivors,” said lead author Carol DeSantis, MPH, American Cancer Society epidemiologist. “Despite the fact that awareness of survivorship issues has increased, cancer survivors face numerous, important hurdles created by a fractured health care system, poor integration of survivorship care, and financial and other barriers to quality care, particularly among the medically underserved. An important first step in addressing these challenges is to identify ‘best practices' for the delivery of quality post-treatment cancer care.”

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs